目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown

Chapter- 2: Summary and Highlights
Market Outlook
Highlights of the Artificial Organs Market

Chapter- 3: Market Overview and Definitions
Overview

Chapter- 4: Market Trends
Market Drivers
Market Opportunity
Market Restraints

Chapter- 5: Market Breakdown by Product Type
Introduction
Artificial Heart
Artificial Kidney
Artificial Lung
Artificial Pancreas
Cochlear Implant

Chapter- 6: COVID-19 Impact Analysis
Introduction
COVID-19 Impact on the Medical Devices and Pharmaceutical Industries
Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments
COVID-19 Impact on Artificial Organs Markets

Chapter- 7: Market Breakdown by Region
Market Overview and Discussion
North America
Latin America
Europe
Asia-Pacific
Rest of the World

Chapter- 8: Competitive Landscape
Industry Scenario
Company Shares

Chapter- 9: Emerging/ Upcoming Technologies
Key/Emerging Technologies/Trends in the Market
Tissue Engineering and Regenerative Medicine
Organ-on-a-Chip
Bio-fabrication and 3D Bioprinting
Biomaterials and Biocompatible Materials
Immunomodulation and Immunotolerance Strategies
Neural Interfaces and Brain-Machine Interfaces
Gene Editing and Gene Therapy

Chapter- 10: M&A and Fundings Outlook
M&A Analysis

Chapter- 11: Sustainability in Artificial Organs Market: An ESG Perspective
Introduction
Environmental Factors
Social Factors
Governance Factors
Artificial Organs Market: ESG Performance Analysis, by Company

Chapter- 12: Patent Analysis
Patent Analysis by Manufacturer

Chapter- 13: Pipeline Analysis
Clinical Trials Scenario

Chapter- 14: Company Profiles
ABIOMED
ABBOTT
BAXTER INTERNATIONAL INC.
B. BRAUN SE
COCHLEAR LTD.
FRESENIUS MEDICAL CARE AG & CO. KGAA
F. HOFFMANN-LA ROCHE AG
GETINGE AB
INSULET CORP.
LIVANOVA PLC
MEDTRONIC
MED-EL MEDICAL ELECTRONICS
NIPRO CORP.
SONOVA
TERUMO CORP.
TANDEM DIABETES CARE, INC.
YPSOMED AG